120 related articles for article (PubMed ID: 20336417)
1. Migraine models.
Benemei S; De Cesaris F; Nicoletti P; Materazzi S; Nassini R; Geppetti P
Methods Mol Biol; 2010; 617():105-14. PubMed ID: 20336417
[TBL] [Abstract][Full Text] [Related]
2. Migraine.
Benemei S; Nicoletti P; Capone JG; De Cesaris F; Geppetti P
Handb Exp Pharmacol; 2009; (194):75-89. PubMed ID: 19655105
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine.
Levy D; Burstein R; Strassman AM
Ann Neurol; 2005 Nov; 58(5):698-705. PubMed ID: 16240341
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
[TBL] [Abstract][Full Text] [Related]
5. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
[TBL] [Abstract][Full Text] [Related]
6. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
Durham PL; Cady R; Cady R
Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
[TBL] [Abstract][Full Text] [Related]
7. The role of CGRP and nicotinic receptors in centrally evoked facial blood flow changes.
Just S; Arndt K; Doods H
Neurosci Lett; 2005 Jun 10-17; 381(1-2):120-4. PubMed ID: 15882801
[TBL] [Abstract][Full Text] [Related]
8. Cortical spreading depression and calcitonin gene-related peptide: a brief review of current progress.
Wang M
Neuropeptides; 2013 Dec; 47(6):463-6. PubMed ID: 24220568
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyopathy in streptozotocin-induced diabetes involves intra-axonal accumulation of calcitonin gene-related peptide and altered expression of its receptor in rats.
Chottová Dvoráková M; Kuncová J; Pfeil U; McGregor GP; Svíglerová J; Slavíková J; Kummer W
Neuroscience; 2005; 134(1):51-8. PubMed ID: 15951122
[TBL] [Abstract][Full Text] [Related]
10. Is there a correlation between spreading depression, neurogenic inflammation, and nociception that might cause migraine headache?
Ebersberger A; Schaible HG; Averbeck B; Richter F
Ann Neurol; 2001 Jan; 49(1):7-13. PubMed ID: 11198299
[TBL] [Abstract][Full Text] [Related]
11. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.
Bolay H; Reuter U; Dunn AK; Huang Z; Boas DA; Moskowitz MA
Nat Med; 2002 Feb; 8(2):136-42. PubMed ID: 11821897
[TBL] [Abstract][Full Text] [Related]
13. Effect of a calcitonin gene-related peptide-binding L-RNA aptamer on neuronal activity in the rat spinal trigeminal nucleus.
Fischer MJM; Schmidt J; Koulchitsky S; Klussmann S; Vater A; Messlinger K
J Headache Pain; 2018 Jan; 19(1):3. PubMed ID: 29335794
[TBL] [Abstract][Full Text] [Related]
14. [Physiopathology of the migraine attack and mechanisms of action of anti-migraine agents: recent findings in animals].
Mick G
Pathol Biol (Paris); 2000 Sep; 48(7):593-607. PubMed ID: 11072637
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
[TBL] [Abstract][Full Text] [Related]
16. Glyceroltrinitrate facilitates stimulated CGRP release but not gene expression of CGRP or its receptor components in rat trigeminal ganglia.
Eberhardt M; Neeb L; Vogel EM; Tiegs G; Reuter U; Messlinger K; Fischer MJ
Neuropeptides; 2009 Dec; 43(6):483-9. PubMed ID: 19864020
[TBL] [Abstract][Full Text] [Related]
17. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
18. CGRP mechanism antagonists and migraine management.
Karsan N; Goadsby PJ
Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
[TBL] [Abstract][Full Text] [Related]
19. Potential role of female sex hormones in the pathophysiology of migraine.
Gupta S; Mehrotra S; Villalón CM; Perusquía M; Saxena PR; MaassenVanDenBrink A
Pharmacol Ther; 2007 Feb; 113(2):321-40. PubMed ID: 17069890
[TBL] [Abstract][Full Text] [Related]
20. Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine.
Piper RD; Edvinsson L; Ekman R; Lambert GA
Cephalalgia; 1993 Jun; 13(3):180-3; discussion 149. PubMed ID: 8395344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
